Yunkang Group participated in S&P Global CSA for the first time Ranks above 89% of participating global peers
HONG KONG, April 9, 2024 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its score in the "S&P Global Corporate Sustainability Assessment" ("S&P Global CSA"). The Group was invited to partic...
Yunkang Announces 2023 Annual Results, Revenue Reaches RMB892 Million
Steps up R&D investment Focuses on precision medicine and intelligent testing sectors HONG KONG, March 25, 2024 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Code: 2325), a leading medical operation services provider in China, has announced its annual results for the year...
Yunkang Group Announces First Annual Results Since Listing
Revenue increases by 121.4% to RMB 3,756 million Profit attributable to owners of the Company of RMB 377 million Three major businesses grow rapidly through in-depth service and lean management HONG KONG, March 31, 2023 /PRNewswire/ -- Yunkang Group Limited ("Yunkang" or the "Group"; Stock Cod...
